Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery

Authors: Moreira, A., Poulet, A., Masliah-Planchon, J., Lecerf, C., Vacher, S., Larbi Chérif, L., Dupain, C., Marret, G., Girard, E., Syx, L., Hoffmann, C., Jeannot, E., Klijanienko, J., Guillou, I., Mariani, O., Dubray-Vautrin, A., Badois, N., Lesnik, M., Choussy, O., Calugaru, V., Borcoman, E., Baulande, S., Legoix, P., Albaud, B., Servant, N., Bieche, I., Le Tourneau, C., Kamal, M.

Source: In ESMO Open August 2021 6(4)

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial

Authors: de Guillebon, E., Jimenez, M., Mazzarella, L., Betsou, F., Stadler, P., Peták, I., Jeannot, E., Chanas, L., Servant, N., Marret, G., Duso, B.A., Legrand, F., Kornerup, K.N., Bernhart, S.H., Balogh, G., Dóczi, R., Filotás, P., Curigliano, G., Bièche, I., Guérin, J., Dirner, A., Neuzillet, C., Girard, N., Borcoman, E., Larbi Chérif, L., Tresca, P., Roufai, D.B., Dupain, C., Scholl, S., André, F., Fernandez, X., Filleron, T., Kamal, M., Le Tourneau, C.

Source: In ESMO Open June 2021 6(3)

69TiP A pilot study of combined biomarker-based treatment strategies in patients with recurrent/metastatic squamous cell carcinoma of the cervix: RAIDS molecular targets trial for cervical cancer

Authors: Bello Roufai, D., Sadozye, A., Glasspool, R.M., Limaye, S., Mandic, A., Popovic, M., Ottevanger, N., Roxburgh, P., Lecuru, F., Larbi Cherif, L., Kamal, M., Le Tourneau, C., Rouzier, R., Scholl, S.

Source: In Annals of Oncology October 2020 31 Supplement 5:S1238-S1238